Wells Fargo initiates coverage on LeMaitre Vascular with 'equal weight' rating

LeMaitre Vascular

13/02/2025 16:49

** Brokerage Wells Fargo initiates coverage on medtech firm
LeMaitre Vascular  LMAT.O  with an "equal weight" rating and a
PT of $95  
    ** Brokerage says LMAT could be poised for growth in 2025 if
it pursues strategic mergers and acquisitions; adds that the
company has $300 million available for deals that could bolster
its device portfolio 
        ** Wells Fargo observes LMAT may acquire companies that
make surgical sealants, devices that block blood flow and clips
for tying off blood vessels 
  
        ** "We believe that the stock fully prices in an
optimistic outlook for pricing and volume growth in 2025 and
beyond" - brokerage
        ** Stock up about 55% in the last 12 months  
  

 (Reporting by Padmanabhan Ananthan)
 ((Padmanabhan.Ananthan@thomsonreuters.com;))